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Brief Technique ReportsSuccessful use of the HeartWare HVAD rotary blood pump for
biventricular supportMartin Strueber, MD, Anna L. Meyer, MD, Doris Malehsa, MD, and Axel Haverich, MD, Hannover,
GermanyLeft ventricular assist devices (LVADs) using rotary
blood pump technology led to significant improvement of
results in left ventricular failure.1 However, patients with
concomitant right ventricular failure have not benefited
from this new technology so far. We report on the first suc-
cessful use of 2 HeartWare HVAD centrifugal pumps
(HeartWare International, Inc, Framingham,Mass) in biven-
tricular support.CLINICAL SUMMARY
A 56-year-old man was referred to our institution after
massive myocardial infarction owing to occlusion of the
left anterior descending coronary artery (LAD) (maximum
creatine kinase MB 1300 units). He had been treated with
grafts to the LAD, the first diagonal, and the right coronary
artery (RCA) and was in cardiogenic shock. An intra-aortic
balloon pump (IABP) and a femorofemoral extracorporeal
membrane oxygenator (ECMO) were implanted after wean-
ing from extracorporeal circulation failed. The patient was
transported to our center after 2 days in an extubated stable
state.
An LVAD was implanted using a standard approach un-
der ECMO support.
All bypass grafts were intact; however, right ventricular
dysfunction led to the decision not to explant the ECMO
or the IABP at this time. The IABP was removed the follow-
ing day, and the ECMO was explanted on postoperative day
4 when renal and liver parameters remained normal. The pa-
tient was treated with phosphodiesterase inhibitor and nitric
oxide. Sedation was instituted for another 3 days, and then
weaning from ventilatory support was started. At this time
the compensated right ventricular insufficiency turned into
refractory right ventricular failure inducing renal insuffi-
ciency and impairment of liver function. A new ECMO
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936 The Journal of Thoracic and Cardiovascular Surgfunction recovered, but right heart failure persisted as indi-
cated by echocardiographic findings for another 10 days,
and the decision was made to implant a second HVAD de-
vice to support the right ventricle. With the patient still sup-
ported by ECMO, the anterior wall of the right ventricle was
chosen for implantion of the inflow of the device. The sew-
ing ring was placed epicardially. Care was taken not to insert
the whole length of the inflow cannula, but only about 1 cm
into the cavity of the ventricle. The location of the device
was stabilized by the epicardial sewing ring.
The bend relief was removed and after partial clamping
the outflow graft was sewn end to side to the main pulmo-
nary artery (Figure 1).
For continuous pressure monitoring, a catheter was in-
serted into the left atrium (LA). The LVAD was set to rela-
tivey high speed (3600 rpm) and the right ventricular assist
device (RVAD) was started at a pump speed of 2000 rpm.
TheECMOcould be stopped and removed. Therewere stable
circulatory conditions with a pump flow of 4.5 to 5.5 L/min
on the LVAD and an LA pressure between 3 and 9 mm Hg.
After the start of spontaneous breathing, the pump flow on
the RVAD changed by the breathing pattern, with very highFIGURE 1. Chest x-ray film showing 2 HeartWare HVAD pumps in
biventricular support.
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FIGURE 2. High-resolution log file of the right and left ventricular assist devices (RVAD and LVAD) showing the flow and speed of both devices over
a period of 40 seconds.
Brief Technique Reportspump flows at inhalation (Figure 2). This resulted in changes
of LA pressure (mean, 3; maximum, 12 mm Hg) increasing
sharply at every inspiration and a constant alarm from the
RVAD controller, indicating false low flow. Clinically, the
patient remained well supported with the 2 devices, ambula-
tory and exercising to improve his physical state for future
heart transplantation. On echocardiography, there was no
sign of congestion or dysfunction of the RVAD. The tricus-
pid valve was sufficient and there was no backward flow
from the device. The flow alarm of the RVADwas turned off.
Currently, the patient has been supported by both devices
for 180dayswithout any adverse events. Thepatient is depen-
dent on 2 controllers and 4 batteries. A standard protocol for
anticoagulation (international normalized ratio, 2.5; clopi-
dogrel 75 mg) was used. Home discharge was considered,
but because of the novelty of this approach the patient is being
kept in the hospital until transplantation. Concerns were
raised because of the potential danger of overflowing the pul-
monary circulation. Therefore, the inclusionof a resistance el-
ement (or banding) into the outflow of this device wasThe Journal of Thoracic and Casuggested to operate the pump at higher speeds to avoidmajor
flow changes. The device functions well without a resistance
element, but the RVAD flow estimation remains erratic.
Owing to the isolated LAD occlusion, recovery of the
right ventricle was expected. Probably the presence of addi-
tional significant stenosis of the dominant RCA led to persis-
tence of right heart failure.
There have been attempts2 before to introduce rotary
blood pumps into patients with biventricular failure, and
we think this successful case will promote this idea even fur-
ther. With minor modifications in the peripheral equipment
and more research on the hemodynamics in long-term sup-
port, rotary blood pump technology may provide an alterna-
tive in destination therapy for biventricular failure.
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